[13C]Nandrolone Excretion in Trained Athletes: Interindividual Variability in Metabolism

Clinical Chemistry

Volumn 50, Issue 2, 2004, Pages 355-364

  Baume, Norbert ^a   Avois, Lidia ^a   Schweizer, Carine ^a   Cardis, Christine ^a   Dvorak, Jiri ^b   Cauderay, Michel ^c   Mangin, Patrice ^a   Saugy, Martial ^a,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b FIFA MEDICAL CENTRE OF EXCELLENCE   (Switzerland)

^c Hopital Riviera   (Switzerland)

^d UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; NANDROLONE; 19 NORANDROSTERONE; 19-NORANDROSTERONE; CARBON; ESTRANE DERIVATIVE;

ADULT; ARTICLE; ATHLETE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEHYDRATION; EXCRETION; FEMALE; GAS CHROMATOGRAPHY; GENETIC VARIABILITY; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; NORMAL HUMAN; TRAINING; URINALYSIS; DOPING; MASS FRAGMENTOGRAPHY; SPORT; SUBSTANCE ABUSE; URINE;

ADULT; CARBON ISOTOPES; DOPING IN SPORTS; ESTRANES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; NANDROLONE; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 0742321921     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.022848     Document Type: Article

References (47)

1. Griffin JE, Wilson JD. Disorders of the testes and the male reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology, 9th ed. Philadelphia: WB Saunders Co., 1998:819-75.
2. Basaria S, Wahlstrom JT, Dobs A. Clinical review 138. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001;86:5108-17.
3. Morant J, ed. Compendium Suisse des medicaments, 24th ed. Bâle: Documed SA, 2003:3052pp.
4. De Mondenard JP. Historique et évolution du dopage. Ann Toxicol Anal 2000;XII:5-18.
5. Laure P, ed. Dopage et société. Paris: Ellipses, 2000:447pp.
6. Mottram DR, George AJ. Anabolic steroids. Baillieres Clin Endocrinol Metab 2000;14:55-69.
7. Blue JG, Lombardo JA. Steroids and steroid-like compounds. Clin Sports Med 1999;18:667-89.
8. Karsh SB. The pathology of drug abuse. In: Karsh SB, ed. Anabolic steroids, 2nd ed. Boca Raton, FL: CRC Press, 1996:409-29.
9. Engel LL, Alexander J, Wheeler M. Urinary metabolites of administered 19-nortestosterone. J Biol Chem 1958;231:159-64.
10. Massé R, Laliberté C, Tremblay L, Dugal R. Gas chromatographic/ mass spectrometric analysis of 19-nortestosterone urinary metabolites in man. Biomed Mass Spectrom 1985;12:2405-8.
11. Olympic International Committee (IOC). Prohibited classes of substances and prohibited methods. In: Olympic movement antidoping code, appendix A. Lausanne, Switzerland: Olympic International Committee, 1999:95pp.
12. Ciardi M, Ciccoli R, Barbarulo MV, Nicoletti R. Presence of norandrosterone in "normal" urine samples. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (16th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 1999:97-104.
13. Dehennin L, Bonnaire Y, Plou P. Urinary excretion of 19-norandrosterone of endogenous origin in man: quantitative analysis by chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1999;721:301-7.
14. Jeanneau T, Kintz P, Cirimele V, Ludes B. Détermination des concentrations physiologiques de la norandrosterone et de la norétiocholanolone, métabolites urinaires de la nandrolone par CPG/SM. Toxicorama 1999;XI:25-9.
15. Kintz P, Cirimele V, Ludes B. Norandrosterone et noré tiocholanolone: les metabolites révélateurs. Acta Clin Belg Suppl 1999; 1:68-73.
16. Le Bizec B, Monteau F, Gaudin I, André F. Evidence for the presence of endogenous 19-norandrosterone in human urine. J Chromatogr B Biomed Appl 1999;723:157-72.
17. Humbert L, L'Hermite M, Vayssette F, Pépin G, Descamps F, Ghysel MH, et al. Détermination des concentrations physiologiques de la norandrosterone et de la norétiocholanolone, métabolites urinaires de la nandrolone par CPG/SM. Résultats d'une étude multicentrique. Annal Toxicol Anal 2000;XII:36-42.
18. Van Eenoo P, Delbeke FT, De Jong FH, De Backer P. Endogenous origin of norandrosterone in female urine: indirect evidence for the production of 19-norsteroids as by-products in the conversion from androgen to estrogen. J Steroids Biochem Mol Biol 2001; 78:351-7.
19. Saugy M, Robinson N, Cardis C, Shweizer C, Rivier L, Mangin P, et al. Nandrolone metabolites in football players: utility for in and out of competition tests. In: Schànzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (17th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 2000:95-108.
20. Robinson N, Taroni F, Saugy M, Ayotte C, Mangin P, Dvorak J. Detection of nandrolone metabolites in urine after a football game in professional and amateur players: a Bayesian comparison. Forensic Sci Int 2001;122:130-5.
21. Schmitt N, Flament MM, Goubault C, Legros P, Grenier-Loustalot MF, Denjean A. Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc 2002;34: 1436-9.
22. Ayotte C. Nutritional supplements and doping controls. IAAF new studies in athletics. Aachen, Germany: Meyer & Meyer Sport 1999;14:37-42.
23. Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA, et al. Trace contamination of over-the-counter androstenedione and positive urine test result for a nandrolone metabolite. JAMA 2000;284:2618-21.
24. De Cock KJS, Delbeke FT, Van Eenoo P, Desmet N, Roels K, De Backer P. Detection and determination of anabolic steroids in nutritional supplements. J Pharm Biomed Anal 2001;25:843-52.
25. Geyer H, Mareck-Engelke U, Wagner A, Schänzer W. The analysis of "non-hormonal" nutritional supplements for prohormones. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (19th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 2001: 63-71.
26. Pipe A, Ayotte C. Nutritional supplements and doping. Clin J Sports Med 2002;12:245-9.
27. Schänzer W. Analysis of non-hormonal nutritional supplements for anabolic steroids, an international study. IOC continuing information. http://multimedia.olympic.org/pdf/en_report_324.pdf (Accessed December 2002).
28. Becchi M, Aguilera R, Farizon Y, Flament MM. Casabianca H, James P. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 1994;8: 304-8.
29. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, et al. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 1996;31:169-76.
30. 12C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (14th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss. 1997: 275-83.
31. Shackleton CHL, Phillips A, Chang T, Li Y. Confirming testosterone administration by isotope ratio mass spectrometry analysis of urinary androstanediols. Steroids 1997;62:379-87.
32. 12C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (15th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 1998:135-48.
33. Aguilera R, Catlin DH, Becchi M, Phillips A, Wang C, Swerdloff RS, et al. Screening urine for exogenous testosterone by isotope ratio mass spectrometry analysis of one pregnanediol and two androstanediols. J Chromatogr B Biomed Appl 1999;727:95-105.
34. Aguilera R, Chapman TE, Starcevic B, Hatton CK, Catlin DH. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios. Clin Chem 2001;47:292-300.
35. Ayotte C, Goudreault D, Lajeunesse A, Cléroux M, Richard Y, Charlebois A, et al. GC/C/IRMS and GC/MS in "natural" steroids testing. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (19th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 2001:133-43.
36. Ueki M, Takato Y, Okano M, Ikekita A, Sato M. Differentiation of endogenous and exogenous steroids in urine by means of isotope mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (19th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 2001:145-54.
37. Catlin D, Cowan D, Donike M, Fraisse D, Oftebro H, Rendic S. Testing urine for drugs. Clin Chim Acta 1992;207:S13-26.
38. Massé R, Ayotte C, Dugal R. Integrated methodological approach to the gas chromatographic-mass spectrometric analysis of anabolic steroid metabolites in urine. J Chromatogr 1989;489:23-50.
39. Chung B, Choo H-Y, Kim T, Eom K, Kwon O, Suh J, et al. Analysis of anabolic steroids using GC/MS with selected ion monitoring. J Anal Toxicol 1990;14:91-5.
40. Schänzer W, Donike M. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 1993;275:23-48.
41. Geyer H, Mareck-Engelke U, Schänzer W, Donike M. Simple purification of urine samples for improved detection of anabolic and endogenous steroids. In: Douike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S, eds. Recent advances in doping analysis (11th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 1994:97-103.
42. Ayotte C, Goudreault D, Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J Chromatogr B 1996; 687:3-25.
43. Schänzer W, Breidbach A, Geyer H, Van Kuk C, Nolteernsting E, Thevis M. Metabolism of nortestosterone, norandrostenedione and norandrostenediol. Identification of 3α-hydroxyestr-4-en-17-one glucuronide and 3α,16α-dihydroxy-5α-estran-17-one glucuronide and sulphate. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U, eds. Recent advances in doping analysis (18th Cologne Workshop on Dope Analysis). Köln, Germany: Sport and Buch Strauss, 2000:155-74.
44. Uralets VP, Gillette PA. Over-the-counter anabolic steroids 4-androstene-3,17-dione; 4-androstene-3α,17α-diol, and 19-nor-androstene-3,17-dione: excretion studies in men. J Anal Toxicol 1999;23:357-66.
45. Uralets VP, Gillette PA. Over-the-counter Δ5 anabolic steroids 5-androstene-3,17-dione; 5-androstene-3β,17β-diol; dehydroepiandrosterone and 19-nor-5-androstene-3,17-dione: excretion studies in men. J Anal Toxicol 2000;24:188-93.
46. Carrieri M, Trevisan A, Bartolucci GB. Adjustment to concentration- dilution of spot urine samples: correlation between specific gravity and creatinine. Int Arch Occup Environ Health 2001;74:63-7.
47. Olympic International Committee (IOC). Criteria for reporting low concentrations of anabolic steroids. Olympic movement anti-doping code, appendix 4. Lausanne, Switzerland: Olympic International Committee, 1999:6pp.